QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=E65F5FF2579828E3957F6EC0659BC027;jsessionid=677EECDC2D7985905AF7B6B9C29A8B4D;jsessionid=A9FD8FD838B2E121E5D87788BDB58D3D;jsessionid=618B5DDCDFA8E1C09312370A2CD07D7D;jsessionid=BB1B204192F7F487B5CC05A1C84BF3F0 (gene)

1. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
2. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
3. The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissue…
4. Ataxin-2 gene: a powerful modulator of neurological disorders.
5. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=E65F5FF2579828E3957F6EC0659BC027;jsessionid=677EECDC2D7985905AF7B6B9C29A8B4D;jsessionid=A9FD8FD838B2E121E5D87788BDB58D3D;jsessionid=618B5DDCDFA8E1C09312370A2CD07D7D;jsessionid=BB1B204192F7F487B5CC05A1C84BF3F0